Found: 14
Select item for more details and to access through your institution.
Veno-occlusive disease/sinusoidal obstruction syndrome in patients with prior gemtuzumab ozogamicin: literature analysis of survival after defibrotide treatment.
- Published in:
- 2020
- By:
- Publication type:
- Letter
ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children's Oncology Group AAML0531 Trial.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 6, p. N.PAG, doi. 10.1038/s41408-019-0211-y
- By:
- Publication type:
- Article
Population Pharmacokinetic Modeling of Gemtuzumab Ozogamicin in Adult Patients with Acute Myeloid Leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00057
- By:
- Publication type:
- Article
Population Pharmacokinetics of Gemtuzumab Ozogamicin in Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Preparation of Enzyme-Activated Thapsigargin Prodrugs by Solid-Phase Synthesis.
- Published in:
- Molecules, 2018, v. 23, n. 6, p. 1463, doi. 10.3390/molecules23061463
- By:
- Publication type:
- Article
Patient-reported outcomes from a phase 3 randomized controlled trial of inotuzumab ozogamicin versus standard therapy for relapsed/refractory acute lymphoblastic leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Assessment of clinical immunogenicity of inotuzumab ozogamicin in patients with non-Hodgkin lymphoma and acute lymphoblastic leukemia.
- Published in:
- AAPS Open, 2018, v. 4, n. 1, p. 0, doi. 10.1186/s41120-018-0021-5
- By:
- Publication type:
- Article
Crystal structure of O-methyltransferase CalO6 from the calicheamicin biosynthetic pathway: a case of challenging structure determination at low resolution.
- Published in:
- BMC Structural Biology, 2015, v. 15, p. 1, doi. 10.1186/s12900-015-0040-6
- By:
- Publication type:
- Article
Mylotarg has potent anti-leukaemic effect: a systematic review and meta-analysis of anti-CD33 antibody treatment in acute myeloid leukaemia.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 3, p. 361, doi. 10.1007/s00277-014-2218-6
- By:
- Publication type:
- Article
Profile of inotuzumab ozogamicin and its potential in the treatment of acute lymphoblastic leukemia.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2014, v. 4, p. 1, doi. 10.2147/BLCTT.S49048
- By:
- Publication type:
- Article
Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 15, p. 2728, doi. 10.1002/cncr.28136
- By:
- Publication type:
- Article
AKT Signaling as a Novel Factor Associated with In Vitro Resistance of Human AML to Gemtuzumab Ozogamicin.
- Published in:
- PLoS ONE, 2013, v. 8, n. 1, p. 1, doi. 10.1371/journal.pone.0053518
- By:
- Publication type:
- Article
Successful treatment with low-dose gemtuzumab ozogamicin in combination chemotherapy followed by stem cell transplantation for children with refractory acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 5, p. 666, doi. 10.1111/j.1365-2141.2012.09192.x
- By:
- Publication type:
- Article